Article Details
Retrieved on: 2021-10-04 11:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AZD2936 is derived from COM902, Compugen's high-affinity clinical-stage anti-TIGIT antibody. "We are proud that AstraZeneca's TIGIT bispecific program, derived ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here